Cosmix did not get a clean equity endorsement in Herbal Super Supplements. The room moved toward a royalty structure instead, which usually means investors saw revenue potential but wanted protection before fully underwriting the long-term upside story.
What the founders were really selling
The useful question here is not whether the startup sounded exciting, but whether it sounded durable.
How the deal reshaped the math
The final pricing held at the founders' own valuation frame. When that happens, it usually means the room accepted both the story and the leverage attached to the ask.
The cleanest way to read the deal is to compare the founders’ opening frame with the price investors were actually willing to underwrite.
The deal effectively held the founders’ own pricing frame at ₹100.00 Cr. Matching the ask is a strong signal that the room accepted both the story and the founder leverage behind it.
Final terms: ₹ 1 Crore for 1% Equity + 1% Royalty till 1 Crore is Recouped....
Equity on the table matters too. At 1%, the founders were trading ownership for speed, validation, and access, not just the cheque itself.
The final valuation matched the ask at ₹100 Cr — the founders got exactly what they wanted.
At just 1% equity, the founders retained strong control — a sign of high leverage in negotiations.
Where the leverage moved
Royalty structures are what investors reach for when they want downside protection before they want long-duration equity exposure. In practical terms, that means the room liked the cash-generation story more than the long-term compounding story.
The room dynamics tell us who had leverage once conviction had to turn into terms.
Royalty-heavy structures usually show that investors wanted downside protection before they wanted full-duration equity exposure. That changes the quality of the “yes.”
Investors involved: Namita Thapar.
The deal closed on royalty terms — a structure sharks use when they want returns without committing to a long equity hold. This often signals the shark sees revenue upside but has reservations about long-term scalability.
What we would watch next
Invest here should be read with caution. The deal got done, but on terms designed to protect the investor first. That changes the quality of the win.
The founder takeaway is not “copy this pitch.” It is understanding what the room rewarded and what it quietly discounted.
INVEST. The business got funded, but on terms that protected the investor more than they celebrated the founder story.
CONDITIONAL. The royalty structure means Namita Thapar gets guaranteed returns before the founders see upside. It's a deal that works if revenue keeps flowing, but it can choke growth if the royalty payments eat into reinvestment capacity.
- Revenue-linked capital can relieve short-term pressure while quietly making reinvestment harder later.
- The strongest lesson is usually not the pitch theatre, but how clearly the founders defended the business when challenged.
- Matching the ask is usually a sign that the founders kept the room anchored to their own frame instead of getting dragged into defensive math.
- Royalty money can solve short-term funding pressure while quietly reducing future reinvestment capacity.
- In Herbal Super Supplements, category excitement alone is rarely enough. Investors still want evidence that the business can scale without the story collapsing under margin, trust, or repeatability pressure.